FTC Takes Androgel Pay-For-Delay Case To High Court
The Federal Trade Commission on Thursday asked the U.S. Supreme Court to review the dismissal of the agency's antitrust challenge to patent settlements Solvay Pharmaceuticals Inc. had penned with several generics...To view the full article, register now.
Already a subscriber? Click here to view full article